| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 1984 | 2007 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 1991 | 2014 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2005 | 2013 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2002 | 2007 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2005 | ||||||||
|
leucyl and cystinyl aminopeptidase | 0.514 | 0.731 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2009 | 2011 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2012 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
cyclin H | 0.595 | 0.769 | 8.1E-04 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1994 | 2009 | ||||||||
|
arginyl aminopeptidase | 0.705 | 0.385 | 2.6E-17 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
prohibitin | 0.511 | 0.846 | 0.76 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2007 | 2016 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2011 | 2016 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2003 | 2003 |